Faecal calprotectin in children with clinically quiescent inflammatory bowel disease

By Sipponen Taina   Kolho Kaija-Leena  

Scandinavian Journal of Gastroenterology, Vol. 45, Iss. 7-8, 2010-08 ,pp. : 872-877

Informa Healthcare

Access to resources Recommend Favorite

Fecal Calprotectin Is a Useful Marker for Disease Activity in Pediatric Patients with Inflammatory Bowel Disease

By Aomatsu Tomoki  

Digestive Diseases and Sciences, Vol. 56, Iss. 8, 2011-08 ,pp. : 2372-2377

Springer Publishing Company

Access to resources Recommend Favorite

Mucosal and Invading Bacteria in Patients with Inflammatory Bowel Disease Compared with Controls

By Kleessen B.   Kroesen A. J.   Buhr H. J.   Blaut M.  

Scandinavian Journal of Gastroenterology, Vol. 37, Iss. 9, 2002-09 ,pp. : 1034-1041

Informa Healthcare

Access to resources Recommend Favorite

Rectal nitric oxide and fecal calprotectin in inflammatory bowel disease

By Reinders Claudia   Jonkers Daisy   Jansson Emmelie Å.   Stockbrügger Reinhold   Stobberingh Ellen   Hellström Per   Lundberg Jon  

Scandinavian Journal of Gastroenterology, Vol. 42, Iss. 10, 2007-01 ,pp. : 1151-1157

Informa Healthcare

Access to resources Recommend Favorite

Serum and mucosal S100 proteins, calprotectin (S100A8/S100A9) and S100A12, are elevated at diagnosis in children with inflammatory bowel disease

By Leach Steven   Yang Zheng   Messina Isabella   Song Changjie   Geczy Carolyn   Cunningham Anne   Day Andrew  

Scandinavian Journal of Gastroenterology, Vol. 42, Iss. 11, 2007-01 ,pp. : 1321-1331

Informa Healthcare

Access to resources Recommend Favorite